Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Guardion Health Sciences Inc (GHSI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 30,410
  • Shares Outstanding, K 22,491
  • Annual Sales, $ 940 K
  • Annual Income, $ -7,770 K
  • 60-Month Beta N/A
  • Price/Sales 34.38
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.28 +10.16%
on 06/18/19
2.20 -35.91%
on 06/04/19
-0.01 (-0.70%)
since 05/17/19

Most Recent Stories

More News
Guardion Launches Second Ocular Health Formula 'GlaucoCetin'

In an IRB-approved trial conducted at the New York Eye and Ear Infirmary, the parent compound of GlaucoCetin, GlaucoHealth, designed by Robert Ritch, MD, successfully reversed mitochondrial dysfunction...

GHSI : 1.41 (+4.28%)
Guardion's Lumega-Z Formula Associated with Substantial Clinical Improvement in Patients Contrast Sensitivity Visual Function (CSF) vs AREDS 2

In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, improvements in visual function (CSF) in the Lumega-Z Group were statistically significant...

GHSI : 1.41 (+4.28%)
Biotech Stocks: Global Revenues for Ophthalmology Market Projected to Reach $26 Billion by 2022

As the baby boomer generation ages, there is an increased need no a demand by these aging patients to avert vision and blindness problems that come with aging. An industry report GBI Research stated that...

PTCT : 42.90 (+0.37%)
GHSI : 1.41 (+4.28%)
RMTI : 3.12 (+2.97%)
BSGM : 8.80 (+4.14%)
VRAY : 9.11 (-0.22%)
Guardion's Lumega-Z Formula Associated with Improved Vision in Patients with Severe Glaucoma

In a recent study presented at the Association for Research in Vision and Ophthalmology (ARVO) 2019 annual meeting, treatment with Lumega-Z was associated with significant improvement in Visual Field function...

GHSI : 1.41 (+4.28%)
Guardion Health Sciences, Inc. Receives Official Trademark Registrations in China

Guardion's Lumega-Z product and MapcatSF device are key components of its two-pronged evidence-based protocol for the treatment of a depleted macular protective pigment, a known risk factor for age-related...

GHSI : 1.41 (+4.28%)
WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services

WallachBeth Capital, a leading provider of capital markets and institutional execution services, announced the closing of the initial public offering of 1,250,000 shares of common stock at a public offering...

GHSI : 1.41 (+4.28%)
Guardion Health Sciences, Inc. Announces Closing of Initial Public Offering

Guardion Health Sciences Inc. ("Guardion") (Nasdaq: GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and testing technologies...

GHSI : 1.41 (+4.28%)
Guardion Health Sciences, Inc. Announces Pricing of Initial Public Offering

Guardion Health Sciences Inc. ("Guardion") (Nasdaq:GHSI), an ocular health sciences and technologies company that develops, formulates and distributes condition-specific medical foods and...

GHSI : 1.41 (+4.28%)
Trade GHSI with:

Business Summary

Guardion Health Sciences Inc. is an ocular health sciences company. It develops, formulates and distributes condition-specific medical foods supported by evidence-based protocols, with an initial medical food product which addresses a depleted macular protective pigment. The company also developed a...

See More

Key Turning Points

2nd Resistance Point 1.50
1st Resistance Point 1.46
Last Price 1.41
1st Support Level 1.35
2nd Support Level 1.28

See More

52-Week High 4.00
Fibonacci 61.8% 2.96
Fibonacci 50% 2.64
Fibonacci 38.2% 2.32
Last Price 1.41
52-Week Low 1.28

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar